Sunil Healthcare Limited (BOM:537253)
75.30
-0.70 (-0.92%)
At close: Sep 10, 2026
Sunil Healthcare Revenue
Sunil Healthcare had revenue of 189.86M INR in the quarter ending June 30, 2026, a decrease of -16.15%. This brings the company's revenue in the last twelve months to 840.63M, down -0.60% year-over-year. In the fiscal year ending March 31, 2026, Sunil Healthcare had annual revenue of 877.19M with 5.15% growth.
Revenue (ttm)
840.63M
Revenue Growth
-0.60%
P/S Ratio
0.92
Revenue / Employee
5.32M
Employees
161
Market Cap
772.18M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 877.19M | 42.98M | 5.15% |
| Mar 31, 2025 | 834.21M | -67.71M | -7.51% |
| Mar 31, 2024 | 901.92M | -202.99M | -18.37% |
| Mar 31, 2023 | 1.10B | -86.73M | -7.28% |
| Mar 31, 2022 | 1.19B | 285.44M | 31.50% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cochin Minerals and Rutile | 3.42B |
| Narmada Gelatines | 2.26B |
| Natural Capsules | 1.91B |
| Dai-ichi Karkaria | 1.80B |
| India Gelatine & Chemicals | 1.76B |
| Ambica Agarbathies Aroma & Industries | 1.36B |
| Biopol Chemicals | 813.72M |
| Saboo Sodium Chloro | 639.36M |